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Introduction
Approximately 14% of infants born in low- and middle-
income countries have a low birth weight (weighing < 2.50 kg 
at birth).1 It has been reported that in high-income set-
tings, low-birth-weight infants have an increased risk of 
vaccine-preventable diseases, such as pertussis,2 invasive 
pneumococcal disease3–5 and Haemophilus influenzae type b 
(Hib).6 However, it is not known whether such risk exists in 
low-income settings. Timely vaccination of low-birth-weight 
infants, including booster doses, is important because these 
infants have lower passive immunity before vaccination7 and 
may respond sub-optimally to primary vaccination.8 Vac-
cination has similar efficacy and safety in low-birth-weight 
infants compared with non-low-birth-weight infants,8 and 
therefore vaccination is recommended at the same chrono-
logical age as other infants.9
Studies from high-income settings indicate that low-birth-
weight infants are vaccinated later than non-low-birth-weight 
infants.10,11 Regardless of whether they are at increased risk, 
delayed vaccination of low-birth-weight infants prolongs their 
risk period for contracting vaccine-preventable diseases, es-
pecially Hib and Streptococcus pneumoniae,3,12 which are most 
prevalent in the first few months of life. Studies of the effect of 
low birth weight on timely vaccination in low-income settings, 
however, are lacking.
We aimed to measure the timing of vaccination of low-birth-
weight infants compared with non-low-birth-weight infants by 
analysing data from a population-based, prospective cohort 
study in Ghana. Our primary objectives were to assess whether 
low birth weight is a determinant of delayed first and third dose 
diphtheria–tetanus–pertussis (DTP1 and DTP3) vaccination; 
and whether maternal education or socioeconomic status modi-
fied the association between birth weight and vaccination with 
DTP1 and DTP3. As a secondary objective, we aimed to quantify 
other determinants of delayed DTP1 and DTP3 vaccination.
Methods
Study design and setting
We studied a cohort of infants nested within a large random-
ized, double-blind, placebo-controlled trial of neonatal vita-
min A supplementation conducted in Ghana between August 
2010 and February 2013.13 The trial was conducted at the Kin-
tampo Health Research Centre in Kintampo, Ghana. The trial 
procedures and study area have been described elsewhere.14
Ethics approval for the study was granted by the ethics 
committees of the World Health Organization (WHO), the 
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DTP vaccination in Ghana is rec-
ommended at 6, 10 and 14 weeks of 
age. Children are vaccinated at health 
facilities, community health planning 
system compounds or mobile outreach 
clinics. For each administered vaccine, 
the date and place of administration 
and vaccine batch number are usually 
documented in the child health record 
book. These may also be documented 
on a vaccination card or in the mother’s 
antenatal card. Infants who have never 
attended a child health clinic may not 
have a written record.
Enrolment and data collection
Trained fieldworkers enrolled all con-
senting women aged 15–49 years resid-
ing in the study area into a reproductive 
surveillance system to document preg-
nancies and deliveries. All infants born 
in the study area were assessed for eligi-
bility (eligible infants were aged ≤ 3 days 
at screening, could suck or feed and were 
staying in the study area for 6 months af-
ter enrolment) and mothers were asked 
for informed written consent for enrol-
ment in the trial. Infants were weighed 
using calibrated electronic (38%; 8723 
of enrolled infants) or spring (62%; 
14 232) scales, to record birth weights to 
the nearest 0.1 kg (electronic scales) or 
0.2 kg (spring scales). Only five (0.2%) 
infants were weighed later than 72 hours 
after delivery. The fieldworkers col-
lected data on infant (sex and multiple 
delivery), maternal (age, education, 
occupation, and illness before delivery) 
and household characteristics (ethnicity, 
religion, socioeconomic status, distance 
to health facility and number of children 
in household).
The enrolled infants were visited 
monthly for the first year of life to col-
lect data on the types and dates of 
vaccines given. We looked for written 
documentation of vaccines from all pos-
sible sources, including the child health 
record book, the mother’s antenatal 
card and vaccination cards. The infant’s 
caregiver (usually the mother) was also 
asked to recall what vaccines had been 
given. We also collected data on the in-
fant’s vital status and on illnesses since 
the previous visit.
Follow-up started at birth. It ended 
at the vaccination date for vaccinated 
infants, and the end of the risk period for 
unvaccinated infants not lost to follow-
up. For those lost to follow-up before the 
end of the risk period, follow-up ended 
on the last date the written record was 
viewed, for unvaccinated infants whose 
record was viewed; or on the last date the 
infant was seen, for unvaccinated infants 
whose record was never viewed; or on 
the date of death, for unvaccinated in-
fants who died before the end of the risk 
period and whose record was viewed 
after their death.
For the analyses we included all in-
fants from the trial with known vaccina-
tion status and dates and with complete 
data on covariates. We excluded infants 
who were lost to follow-up or died be-
fore the vaccination due date.
Definitions
We classified infants’ vaccination status 
as follows: (i) vaccinated, date known 
(written record had a plausible vac-
cination date); (ii) vaccinated, date un-
known (record had clearly documented 
vaccination but with the date missing, 
illegible or implausible); (iii) unvacci-
nated (record was seen but had no docu-
mented vaccination date or any evidence 
of vaccination; or record was never seen 
and mother consistently reported infant 
had never been vaccinated); or (iv) vac-
cination status unknown (mother re-
ported that infant had been vaccinated 
but did not specify the vaccine; or infant 
was never seen in follow-up).
We categorized birth weight into 
four standard categories: ≥ 2.5 kg (i.e. 
non-low birth weight); 2.0–2.4 kg; 
1.5–1.9 kg; < 1.5 kg.1,15
Outcome measures
The study outcomes were delayed receipt 
of DTP1 and DTP3. There is no standard 
































Note: The effects of distal variables were hypothesized to be mediated by intermediate and proximal variables, and intermediate variables by the proximal 
variables. Among the proximal variables, illness was hypothesized to mediate the effect of birth weight. Mediation is indicated by arrows linking the variables 
across different levels.
Bull World Health Organ 2016;94:442–451D| doi: http://dx.doi.org/10.2471/BLT.15.159699444
Research
Delayed vaccination of infants in Ghana Maureen O’Leary et al.
approach to the assessment of delayed 
vaccination and several definitions 
based on predefined cut-offs have been 
described.16–18 To assess how the effect 
of birth weight may vary over time, we 
defined risk periods for delayed vaccina-
tion up to 4, 8 and 12 weeks after the vac-
cination due date. For DTP1 we therefore 
analysed vaccination rates from birth up 
to 10, 14 and 18 weeks of age. For DTP3 
we analysed vaccination from birth up 
to 18, 22 and 26 weeks of age.
Data analysis
The data were double-entered and pro-
cessed at the Kintampo Health Research 
Centre using the SQL Server 2008 data 
management system (Microsoft Corp., 
Redmond, USA). Inconsistencies and 
errors in the vaccination dates were cor-
rected, with senior fieldworkers visiting 
mothers to review the written record 
and verify the dates if necessary.
All analyses were conducted us-
ing the Stata package version 13.1 
(StataCorp, College Station, USA). 
We generated Kaplan–Meier curves of 
time to vaccination in low-birth-weight 
compared with non-low-birth-weight 
infants in the first year of life for DTP1 
and DTP3. Vaccination rate ratios, 
adjusted for a priori selected factors, 
were obtained for each risk period us-
ing multivariable Poisson regression, 
informed by a hierarchical framework 
of the recognized determinants of 
vaccination (Fig. 1).12,16–18 The initial 
model included distal determinants of 
vaccination, then intermediate deter-
minants were added, followed by birth 
weight and, finally, infant illness at the 
time the vaccine was due (as this was 
considered to be a possible mediator of 
the association between birth weight 
and vaccination).19 We assessed the 
statistical association between vacci-
nation and each explanatory variable 
using likelihood ratio tests and 95% 
confidence intervals (CI). We also inves-
tigated whether the association between 
birth weight and vaccination varied by 
maternal education or socioeconomic 
status by testing the interaction of birth 
weight with these variables.
Two sets of sensitivity analyses were 
undertaken. First, to assess whether de-
layed DTP3 vaccination simply reflected 
delayed DTP1 vaccination, we repeated 
the DTP3 analyses, starting follow-up at 
receipt of DTP1 vaccination and ending 
12 weeks after receipt of DTP1. Second, 
to examine the effect of possible misclas-
sification of vaccine status for infants 
categorized as never vaccinated but 
whose written record was never viewed, 
we excluded these infants and repeated 
the analyses of DTP1 vaccination up to 
18 weeks from birth and DTP3 vaccina-
tion up to 26 weeks.
Results
Of 27 330 live births identified in the 
study area, 26 414 infants were screened 
for eligibility for the trial and 22 955 
were enrolled (Fig. 2); 22 361 (97.4%) 
and 22 192 (96.7%) infants were in-
cluded in the analysis of DTP1 and 
DTP3 respectively. Low-birth-weight 
infants were more likely to be excluded 
from our analysis, as were those with 
illness reported around the vaccination 
due date, those from multiple births 
and those born to mothers of lower 
socioeconomic status, of non-Akan eth-
nicity, with lower education, with lower 
employment grades or living more than 
5.0 km from a health facility (Table 1). 
Of the infants included in the DTP1 
analysis, 18 979 (84.9%) were normal 
birth weight and 3382 (15.1%) were 
low birth weight: 2916 (13.0%) weighed 
2.0–2.4 kg, 386 (1.7%) 1.5–1.9 kg and 80 
(0.4%) < 1.5 kg. The birth weight distri-
bution was the same for infants in the 
DTP3 analysis: 18 850 (84.9%) weighed 
≥ 2.5 kg, 2886 (13.0%) 2.0–2.4 kg, 378 




Although uptake of vaccination was 
high (> 95%) for all infants by 1 year 
of age, low birth weight was associated 
with later vaccination for both DTP1 
and DTP3. Median ages at DTP1 vac-
cination were 8 weeks (interquartile 
range, IQR: 6.7–9.6 weeks) for infants 
Fig. 2. Identification, recruitment and inclusion of participants in the prospective 
cohort study on infant vaccination in rural Ghana, 2010–2013
27 330 live births 
identified in study area
26 414 infants screened 
for eligibility (94.7%)
22 955 infants enrolled 
(86.9%)
22 361 infants included in 
analysis of DTP1 (97.4%)
22 192 infants included in 
analysis of DTP3 (96.7%)
916 infants not screened (3.4%)                                                                
• 282 could not be reached by study team (1.0%)               
• 298 died before screening (1.1%)                                                           
• 336 did not provide consent (1.2%)
3459 infants excluded (13.1%)                                                                                                                
• 2500 moving house within 6 months (9.5%)                                
• 800 aged > 3 days (3.0%)                                                                                                                       
• 84 unable to feed or be assessed for feeding (0.3%) 
• 75 other reason (0.3%)    
763 infants excluded (3.3%)                                 
• 408 missing data on vaccination 
status (1.8%)                                                                                                                         
• 274 died or lost to follow-up before 
98 days of age (1.2%)                                                                   
• 38 vaccinated but date of 
vaccination unknown (0.2%)                                     
• 43 missing covariate data (0.2%)  
594 infants excluded (2.6%)                                           
• 398 missing data on vaccination      
status (1.7%)                                                                   
• 124 died or lost to follow-up before 
42 days of age (0.5%)                                    
• 27 vaccinated but date of 
vaccination unknown  (0.1%)                                  
• 45 missing covariate data (0.2%)  
DTP1: first dose of diphtheria–tetanus–pertussis vaccine; DTP3: third dose of diphtheria–tetanus–
pertussis vaccine.
Note: Overall and disaggregated percentages may not agree due to rounding.
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Table 1. Characteristics of infants vaccinated with first and third doses of diphtheria–tetanus–pertussis vaccine in the prospective 








(n = 22 192)
Excluded infants (n = 763)
Distal determinants
Religion of head of household
  Christian 15 616 (69.8) 363 (61.1) 15 497 (69.8) 482 (63.2)
  Muslim 5 333 (23.8) 178 (30.0) 5 294 (23.9) 217 (28.4)
  None/traditional/other 1 412 (6.3) 53 (8.9) 1401 (6.3) 64 (8.4)
Ethnicity of household
  Akan 10 470 (46.8) 223 (37.5) 10 410 (46.9) 283 (37.1)
  Other 11 891 (53.2) 371 (62.5) 11 782 (53.1) 480 (62.9)
Socioeconomic statusa
  1 (poorest) 4 356 (19.5) 155 (26.1) 4 299 (19.4) 212 (27.8)
  2 4 407 (19.7) 143 (24.1) 4 363 (19.7) 187 (24.5)
  3 4 469 (20.0) 113 (19.0) 4 440 (20.0) 142 (18.6)
  4 4 544 (20.3) 100 (16.8) 4 523 (20.4) 121 (15.9)
  5 (richest) 4 585 (20.5) 83 (14.0) 4 567 (20.6) 101 (13.2)
Maternal occupation
  Government/private/other 1 200 (5.4) 25 (4.2) 1 199 (5.4) 26 (3.4)
  Self-employed 8 752 (39.1) 194 (32.7) 8 716 (39.3) 230 (30.1)
  Farming 6 472 (28.9) 199 (33.5) 6 411 (28.9) 260 (34.1)
  Not working 5 937 (26.6) 176 (29.6) 5 866 (26.4) 247 (32.4)
Maternal education
  None 6 913 (30.9) 214 (36.0) 6 845 (30.8) 282 (37.0)
  Primary school 4 115 (18.4) 121 (20.4) 4 081 (18.4) 155 (20.3)
  Secondary/tertiary 11 333 (50.7) 245 (41.2) 11 266 (50.8) 312 (40.9)
  Missing values 0 (0.0) 14 (2.4) 0 (0.0) 14 (1.8)
Season when vaccine due: wet 14 176 (63.4) 382 (64.3) 10 406 (46.9) 347 (45.5)
Infant sex: female 11 025 (49.3) 281 (47.3) 10 938 (49.3) 368 (48.2)
Intermediate determinants
Maternal age (years)
  < 20 2 550 (11.4) 95 (16.0) 2 514 (11.3) 131 (17.2)
  20–24 5 714 (25.6) 173 (29.1) 5 657 (25.5) 230 (30.1)
  25–29 6 017 (26.9) 137 (23.1) 5 986 (27.0) 168 (22.0)
  30–34 4 522 (20.2) 95 (16.0) 4 497 (20.3) 120 (15.7)
  ≥ 35 3 558 (15.9) 64 (10.8) 3 538 (15.9) 84 (11.0)
  Missing value 0 (0.0) 30 (5.1) 0 (0.0) 30 (3.9)
No. of children in family
  0–1 6 516 (29.1) 216 (36.4) 6 450 (29.1) 282 (37.0)
  2–3 8 946 (40.0) 209 (35.2) 8 887 (40.0) 268 (35.1)
  ≥ 4 6 899 (30.9) 169 (28.5) 6 855 (30.9) 213 (27.9)
Maternal illness: yes 1 093 (4.9) 30 (5.1) 1 090 (4.9) 33 (4.3)
Distance from health facility 
(km)
  < 1.0 13 545 (60.6) 342 (57.6) 13 461 (60.7) 436 (57.1)
  1.0–4.9 5 147 (23) 117 (19.7) 5 106 (23.0) 151 (19.8)
  ≥ 5.0 3 669 (16.4) 133 (22.4) 3 625 (16.3) 169 (22.1)
  Missing value 0 (0.0) 2 (0.3) 0 (0.0) 7 (0.9)
Place of birth: health facility 17 155 (76.7) 426 (71.7) 17 047 (76.8) 534 (70.0)
Multiple birth 795 (3.6) 52 (8.8) 784 (3.5) 63 (8.3)
(continues. . .)
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weighing ≥ 2.5 kg at birth; 8.3 weeks 
(IQR: 6.9–9.9) for those 2.0–2.4 kg; 
8.4 weeks (IQR: 6.9–10.7) for those 
1.5–1.9 kg and 9 weeks (IQR: 7.4–11.9) 
for those < 1.5 kg. For DTP3, the cor-
responding median ages at vaccination 
were 18.4 weeks (IQR: 16.3–22.1), 18.6 
weeks (IQR: 16.6–22.3), 19.6 weeks 
(IQR: 16.6–23.3) and 20.4 weeks (IQR: 
17.7–25.1), respectively.
The Kaplan–Meier curves showed 
that DTP1 vaccination rates over the 
days since birth were also lower for 
infants weighing < 1.5 kg and those 
weighing 1.5–1.9 kg compared with 
those weighing ≥ 2.5 kg (Fig. 3). After 
adjustment for other variables, there 
was evidence of progressively delayed 
vaccination with decreasing birth 
weight (P-value for trend < 0.0001). 
Infants weighing < 1.5 kg at birth had 
a DTP1 vaccination rate approximately 
40% lower than non-low-birth-weight 
infants by the age of 10 weeks (ad-
justed rate ratio, aRR: 0.58; 95% CI: 
0.43–0.77) and age 18 weeks (aRR: 
0.63; 95% CI: 0.50–0.80). Infants 
weighing 1.5–1.9 kg had vaccina-
tion rates approximately 25% lower 
than non-low-birth-weight infants 
at these time points (aRR: 0.71; 95% 
CI: 0.62–0.81 and aRR: 0.76; 95% CI: 
0.69–0.85, respectively; Table 2, avail-
able at: http://www.who.int/bulletin/
volumes/94/5/15-159699).
Similar results were observed for 
DTP3 (Fig. 3). The findings were also 
similar for DTP1 and DTP3 vaccination 
at 8 weeks after the due date (Table 2).
Adjusting for illness had little effect 
on the magnitude of the association be-
tween birth weight and vaccination for 
both DTP1 and DTP3 (Table 2).
Other variables
Younger maternal age, lower educational 
attainment, and longer distance to the 
nearest health facility were associated 
with moderate reductions in the DTP1 
and DTP3 vaccination rates of approxi-
mately 10–20% at ages 10 and 18 weeks, 
whereas higher employment grade was 
associated with moderate increased 
vaccination rates at these ages (Table 3, 
available at: http://www.who.int/bulw-
letin/volumes/94/5/15-159699). In the 
final model (after adjusting for potential 
mediating variables) low socioeconomic 
status of mothers was associated with a 
15% increased DTP3 vaccination rate 
at 18 weeks, whereas no association 
with DTP1 vaccination was observed. 
Muslim religion and larger family size 
were associated with > 10% reduction 
in DTP3 vaccination rates but had no, 
or only a small, association with DTP1 
vaccination rates. None of the other 
variables measured had notable associa-
tions with DTP1 or DTP3 vaccination 
rates at any ages.
Sensitivity analyses
Adjusting for late vaccination with 
DTP1 decreased the effect size for the 
association between birth weight and 
the rate of DTP3 vaccination for infants 
weighing 1.5–1.9 kg (12 weeks after 
DTP1 aRR: 0.98; 95% CI: 0.85–1.13) 
compared with an aRR of 0.82 (95% CI: 
0.73–0.92) at 12 weeks after the DTP3 
due date, but the effect size for infants 
weighing < 1.5 kg was largely unchanged 
(Table 2).
Excluding unvaccinated infants 
whose written record was never seen had 
little impact on the effect size of the ex-
planatory variables for DTP1 or DTP3.
Modifying factors
When we looked at other factors that 
might modify the association between 
birth weight and delayed vaccination 
there was no evidence that the effect of 
birth weight on vaccination with DTP1 
or DTP3 varied by socioeconomic status 
(P-values for interaction all > 0.4), or 
that the rate of vaccination with DTP1 
varied by maternal education, when 
measured at age 10 weeks (P = 0.3338) 
or age 18 weeks (P = 0.2675). How-
ever, for DTP3 vaccination there was 
some evidence that the effect of birth 
weight on the vaccination rate at age 
18 weeks (P = 0.0219) and age 26 weeks 
(P = 0.0813) varied with maternal edu-
cation, with a more pronounced reduc-
tion in vaccination rate among smaller 
infants born to mothers with higher 
educational attainment (aRR for infants 
weighing < 1.50 kg at age 18 weeks: 0.37; 
95% CI: 0.19–0.72; aRR at 26 weeks: 
0.63; 95% CI: 0.50–0.80). When infants 
with delayed receipt of DTP1 were ex-
cluded from the analysis, this effect was 
no longer apparent.
Discussion
The results of this study provide evi-
dence that low-birth-weight infants 
in Ghana are vaccinated later than 








(n = 22 192)
Excluded infants (n = 763)
Distal determinants
Birth weight (kg)
  ≥ 2.5 18 979 (84.9) 382 (64.3) 18 850 (84.9) 511 (67.0)
  2.0–2.4 2 916 (13.0) 115 (19.4) 2 886 (13.0) 145 (19.0)
  1.5–1.9 386 (1.7) 58 (9.8) 378 (1.7) 66 (8.7)
  < 1.5 80 (0.4) 37 (6.2) 78 (0.4) 39 (5.1)
  Missing value 0 (0.0) 2 (0.3) 0 (0.0) 2 (0.3)
Mediating variables
Infant illness: yes 2 748 (12.3) 155 (26.1) 3 429 (15.5) 277 (36.3)
  Missing value 0 (0.0) 261 (43.9) 0 (0.0) 329 (43.1)
DTP1: first dose of diphtheria–tetanus–pertussis vaccine; DTP3: third dose of diphtheria–tetanus–pertussis vaccine.
a  Socioeconomic status was calculated by principal components analysis from an inventory of household assets.
(. . .continued)
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fect persisted up to 12 weeks after the 
vaccination due date and was evident 
for both DTP1 and DTP3, even after 
controlling for other determinants of 
delayed vaccination.
The results are consistent with 
previous reports from high-income 
countries of delayed vaccination in 
low-birth-weight infants.10,11,20–22 In ad-
dition, a study of low-birth-weight in-
fants in Guinea-Bissau, which did not 
look at timeliness, reported lower up-
take of DTP1 at 8 weeks of age among 
smaller low-birth-weight infants 
compared with larger low-birth-weight 
infants.23 A North American study re-
ported that both parents and vaccine-
providers had erroneous beliefs that 
initiation of vaccination depended 
on the degree of prematurity and the 
infant’s weight.22 In addition, a review 
of 47 studies in the grey literature 
from low-income settings reported 
parental reluctance to bring sick, weak 
or malnourished children for vaccina-
tion for reasons of social stigma and 
fatalism; these have also been cited as 
reasons for non-vaccination by vaccine 
providers.19
Low-birth-weight infants in low-
income settings are known to have 
higher rates of illness and death in 
the first year of life than non-low-
birth-weight infants.15,24–27 Data from 
high-income settings indicate that they 
also have higher rates of illness from 
vaccine-preventable diseases.2–4,6 The 
risk and consequences of illness related 
to vaccine-preventable diseases in low-
birth-weight infants in low-income 
settings is not known and may differ 
from those in high-income settings. 
Without this information it is difficult 
to fully understand the implications 
of delayed vaccination on clinical out-
comes for these infants. However, we do 
know that delayed vaccination of these 
infants will prolong their risk period for 
contracting these diseases and may also 
reflect an underuse of health services 
by the caregivers of these infants. Given 
this increased risk of illness and death, 
it is essential that all opportunities for 
vaccination and health care for low-
birth-weight infants be exploited.
We also identified several addi-
tional determinants of delayed vaccina-
tion – low maternal age and educational 
attainment and longer distance to the 
nearest health facility – that reflect 
persisting inequities in access to and 
uptake of vaccination in our study 
population. This is consistent with 
previous findings from the study area16 
and the issue of inequities in coverage 
of vaccination have featured in global 
vaccine policy.28
The strengths of our study include 
the high quality population-based sur-
veillance system and low loss to follow-
up. Almost all infants were weighed 
within 72 hours of delivery by trained 
fieldworkers using calibrated scales, thus 
minimizing the likelihood of misclassi-
fication of infants by birth weight. Simi-
larly, we collected high quality data on 
vaccination – from both written records 
and maternal recall – and we employed 
a rigorous approach to resolving incon-
sistencies in these data. Although recall 
data is used in the generation of routine 
vaccine uptake estimates,29 their validity 
may vary.30,31 The validity of our recall 
data was maximized by the continuous 
nature of the data collection in our study. 
Infants with recall data accounted for 
less than 0.6% of all infants included 
in the analyses and had little impact on 
our estimates. Furthermore, the inclu-
sion of over 22 000 infants ensured that 
the study had sufficient power to show 
effects in small subgroups.
Aspects of this study that may have 
affected the generalizability of our find-
ings are that our study sample may have 
experienced more timely vaccination 
Fig. 3. Time to vaccination with first dose and third dose of diphtheria–tetanus–
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DTP1: first dose of diphtheria–tetanus–pertussis vaccine; DTP3: third dose of diphtheria–tetanus–
pertussis vaccine.
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compared with the general population. 
A higher proportion of low-birth-weight 
infants than non-low-birth-weight in-
fants were excluded from our analyses, 
either because they did not meet the in-
clusion criteria for enrolment in the trial 
or because more of them were lost to 
follow-up or had missing data (including 
missing vaccination data) than non-low-
birth-weight infants. Those excluded 
could have experienced greater delay in 
receiving their vaccines compared with 
the included low-birth-weight infants, 
possibly causing some underestimation 
of the association between low birth 
weight and timely vaccination in our 
population. As less than 5% of enrolled 
infants were excluded, this was unlikely 
to have changed the results appreciably 
and important delays in vaccination 
were still observed among low-birth-
weight infants. Mothers of enrolled 
infants were asked about their infant’s 
vaccination status at monthly visits, 
possibly increasing their awareness of 
the need to vaccinate their infants. This 
increased awareness, however, would 
not have been differentially affected by 
birth weight and would lead to an overall 
underestimation of delayed vaccination.
Other limitations are that we did 
not have reliable data on gestational 
age and therefore we were not able to 
assess whether delayed vaccination 
was associated with prematurity or 
whether all low-birth-weight infants 
were affected regardless of gestational 
age. This study was also not designed to 
assess the association between delayed 
vaccination and clinical outcomes such 
as vaccine-preventable diseases or hos-
pitalizations. Consequently, we do not 
know whether those infants who had 
delayed vaccination were more likely to 
contract vaccine-preventable diseases 
or to report elevated rates of illness or 
hospitalization. Eleven explanatory vari-
ables were included in our secondary 
analysis, thus increasing the potential 
for type 1 errors (finding statistically 
significant results by chance alone). 
Finally, we did not collect any qualita-
tive data on the reasons for delayed 
vaccination of low-birth-weight infants 
in our study sample. This limits our 
interpretation of the findings. It may be 
that vaccination was delayed for reasons 
beyond the control of both the caregiv-
ers and the vaccine providers, such as 
lack of vaccines or staff, although it is 
reasonable to assume that these would 
not be distributed differently among 
low-birth-weight compared with non-
low-birth-weight infants.
Recommendations
Current global policy on vaccination 
advocates the identification of groups 
that are underserved by vaccination,28 
yet data on uptake and timeliness of 
vaccination in low-birth-weight infants 
are not currently included in routine 
evaluations of vaccination programmes. 
These data are feasible to collect in 
low-income settings; doing this would 
contribute to a more comprehensive 
evaluation of the performance of vac-
cination programmes and would inform 
the development of strategies to improve 
uptake and timing of vaccination in all 
countries.28 Even though several or-
ganizations in high-income countries 
have made specific recommendations 
about vaccination of low-birth-weight 
infants,9,32 international guidelines are 
lacking.
Efforts to improve the vaccina-
tion of low-birth-weight infants, for 
example by education of caregivers and 
vaccine-providers, are warranted. Fur-
ther research is needed in low-income 
countries to understand the reasons for 
delayed vaccination of low-birth-weight 
infants and to inform strategies to im-
prove the timeliness of vaccination. ■
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صخلم
 :اناغ في ةيفيرلا قطانلما في ةمزلالا تاحاقلل ةدلاولا دنع نزولا ضيفخنم عضرلا لافطلأا يقلت ديعاوم ديدتح
ةيناكس تاعاطق لىع ةمئاق ةيقابتسا ةيبارتأ ةسارد
 حاقللا نم ةثلاثلاو لىولأا ةعرلجا يقلت في رخأتلا ءاصقتسا ضرغلا
 يثلاثلا حاقللا ةعرج( يكيدلا لاعسلاو سوناتيتلاو ايترفدلا دض
 دنع  نزولا  ضيفخنم  عضرلا  لافطلأا  دنع  )DTP3و  DTP1
.كلذب ةطبترلما تاددحلماو ،اناغ في ةدلاولا
 يتلا  فلأ  ينماتيف  ةبرتج  نم  ةدمتسلما  تانايبلا  انمدختسا  ةقيرطلا
 نم ةترفلا  في اهؤارجإ مت يتلاو ةنيعم ةيناكس تاعاطق لىإ دنتست
 اًسايق انيرجأ .هليجست مت عيضر 22,955  لىع 2013  لىإ 2010
 لافطلأاو  تاهملأاب  ةقلعتلما  صئاصلخاو  حاقللا  يقلت  لدعلم
 عضرلا  لافطلأا  نم حئاشر ثلاث ينب  ةنراقم  انيرجأ  ماك  ،عضرلا
 ؛غلك 1.9 – 1.5و ؛غلك 2.4 – 2.0( ةدلاولا دنع نزولا ضيفخنم
 منهزو غلبي نمم عضرلا لافطلأاو بناج نم )غلك 1.5 نم لقلأاو
 جذومن مادختسا متو .رخآ بناج نم كلذ نع ديزي وأ غلك 2.5
 ةعرج نأشب حاقللا يقلت لدعم بسن باستحلا نوساوبل فوحتلا
 دعب  اًعوبسأ  18و  14و  10  غولب  دنع  DTP1  يثلاثلا  حاقللا
 22و 18 غولب دنع DTP3 يثلاثلا حاقللا ةعرج نأشبو ،ةدلاولا
 اًعوبسأ 14و 6 رورم دعب رهشأ 3و 2و 1 يواسي ماب( اًعوبسأ 24و
.)لياوتلا لىع ةروكذلما تاحاقللا يقلت بوجو خيراوت لولح دعب
 دنع  DTP1  يثلاثلا  حاقللا  ةعرج  يقلت  لدعم  ناك  جئاتنلا
 )3382  =  ددعلا(  ةدلاولا  دنع  نزولا  ضيفخنم  عضرلا  لافطلأا
 نوناعي لا نمم عضرلا لافطلأاب ًةنراقم 40% نم برقت ةبسنب لقأ
 في  كلذو  ،)18,979  =  ددعلا(  ةدلاولا  دنع  نزولا  ضافخنا  نم
 ةبسنو  ؛aRR: 0.58  ،ةححصلما  لدعلما  ةبسنب(  عيباسأ  10  رمع
 اًعوبسأ 18 غولب دنعو )0.77 – 0.43 :% 95 اهرادقم ةيحجرأ
 .)0.80–0.50 :% 95  اهرادقم ةيحجرأ ةبسنو ؛aRR: 0.63(
 منهزو غلبي نمم عضرلا لافطلأا دنع حاقللا يقلت تلادعم تناكو
 ًةنراقم  25%  نم  برقت  ةبسنب  لقأ  )386  =  ددعلا(  1.9  -  1.5
 تاقولأا  في  رثكأ  وأ  غلك  2.5  منهزو  غلبي  نمم  عضرلا  لافطلأاب
 ةعرجب  قلعتي  مايف  كلذل  ةبهاشم  جئاتن  تظحول  دقو  .ةروكذلما
 ،تاهملأا نس رغص ينب طابترا ةمث ناكو .DTP3 يثلاثلا حاقللا
 برقأ  لىإ  لوصولل  ةمزلالا  ةفاسلما  دعبو  ،نهميلعت  ةدم  صرقو
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 حاقللا  ةعرج يقلت  تلادعم ضافخناو بناج نم ةيحص ةأشنم
.رخآ بناج نم DTP3و DTP1 يثلاثلا
 ةدلاولا  دنع  نزولا  وضفخنم  عضرلا  لافطلأا  لثمي  جاتنتسلاا
 يقلت  رخأتب  قلعتي  مايف  رطلخا  نم  ةيلاع  ةجردل  ةضرعم  ةعوممج
 زيزعتل  دوهلجا  لذب  ةجالحا  ضيتقتو  .اناغ  في  ةمزلالا  تاحاقللا
 نم ديزلما ءارجإ بناج لىإ ،تاحاقلل عضرلا لافطلأا ءلاؤه يقلت






方 法 我 们 所 采 用 的 数 据 来 源 于 2010-2013 年 间
在 22 955 名接受调查的婴儿中开展的基于群体的大规
模维生素 A 试验。 我们衡量了疫苗接种率和母亲及
婴儿特征，并将三类低出生体重婴儿（2.0–2.4 公斤 ；
1.5–1.9 公斤 ；和不足 1.5 公斤）与出生体重大于或等
于  2.5 公斤的婴儿相比较，并在出生 10、14 和 18 周
后使用泊松回归分析计算 DTP1 疫苗接种率，在 18、
22 和 24 周后计算 DTP3 接种率【相当于两个接种截
止日期（即 6 周和 14 周）后的第 1、2 和第 3 个月】。
结 果 低 出 生 体 重 婴 儿 (n = 3382) 在 第 10 周
时 的 DTP1 接 种 率 大 约 比 非 低 出 生 体 重 婴
儿 (n = 18 979) 低 40% （ 调 整 后 的 优 势 比，aRR: 
0.58; 95% CI: 0.43–0.77），第 18 周 (aRR: 0.63; 95% CI: 
0.50–0.80)。 在所取时间节点，体重在 1.5–1.9 公斤
的婴儿 (n = 386) 接种率大约比体重大于或等于  2.5 公
斤 的 婴 儿 低 25%。 DTP3 的 观 察 结 果 相 似。 较 低






Âge de vaccination des nourrissons au faible poids de naissance dans les zones rurales du Ghana: une étude prospective de 
cohorte menée dans la population
Objectif Examiner les retards d’administration de la première et de 
la troisième dose de vaccin diphtérie–tétanos–coqueluche (DTP1 et 
DTP3) chez les nourrissons au faible poids de naissance au Ghana, 
ainsi que les déterminants associés.
Méthodes Nous avons utilisé les données issues d’un vaste essai 
sur la vitamine A, mené dans la population en 2010–2013, et qui 
portait sur 22 955 nourrissons. Nous avons déterminé le taux de 
vaccination ainsi que les caractéristiques des mères et des enfants 
et avons comparé trois catégories de nourrissons au faible poids de 
naissance (2,0–2,4 kg; 1,5–1,9 kg; et < 1,5 kg) avec des nourrissons 
pesant ≥ 2,5 kg. Une régression de Poisson nous a permis de calculer 
les ratios des taux de vaccination pour le DTP1 à 10, 14 et 18 semaines 
après la naissance et, pour le DTP3, à 18, 22 et 24 semaines (ce qui 
équivaut respectivement à 1, 2 et 3 mois après l’âge normal de 
vaccination qui est de 6 et 14 semaines).
Résultats Comparés aux nourrissons n’ayant pas un faible poids de 
naissance (n = 18 979), ceux au faible poids de naissance (n = 3382) 
avaient un taux de vaccination DTP1 presque 40% plus faible à l’âge 
de 10 semaines (ratio des taux ajusté, RTa: 0,58; IC 95%: 0,43–0,77) et 
à l’âge de 18 semaines (RTa: 0,63; IC 95%: 0,50-0,80). Les nourrissons 
pesant de 1,5 à 1,9 kg (n = 386) avaient un taux de vaccination à ces 
âges environ 25% plus faible que ceux pesant ≥ 2,5 kg. Des résultats 
similaires ont été observés pour le DTP3. Le plus jeune âge des 
mères, leur niveau d’instruction et les distances plus longues jusqu’à 
l’établissement de soins le plus proche étaient associés à de plus 
faibles taux de vaccination DTP1 et DTP3.
Conclusion Les nourrissons au faible poids de naissance sont un 
groupe à haut risque en matière de retard de vaccination au Ghana. 
Des efforts devraient être entrepris pour améliorer la vaccination 
de ces enfants, parallèlement à d’autres recherches permettant de 
comprendre les raisons de ce retard.
Резюме
Сроки проведения вакцинации в сельской местности Ганы для грудных детей со сниженной массой 
тела при рождении: популяционное проспективное когортное исследование
Цель Изучить несоблюдение сроков первой и третьей 
вакцинации против дифтерии, коклюша и столбняка (АКДС1 и 
АКДС3) грудных детей со сниженной массой тела при рождении 
в Гане и связанные с этим определяющие факторы.
Методы Были использованы данные, полученные в результате 
обширного популяционного исследования приема витамина A, 
которое проводилось в 2010–2013 гг. при участии 22 955 грудных 
детей. Был определен охват вакцинацией матерей и грудных 
детей, были выявлены их характеристики, и были сопоставлены 
три категории грудных детей со сниженной (≥2,5 кг) массой тела 
при рождении: 2,0–2,4; 1,5–1,9 и <1,5 кг. С помощью регрессии 
Пуассона были подсчитаны отношения рисков вакцинации 
для вакцинации АКДС1, проведенной на 10, 14 и 18-й неделе 
после рождения, и для вакцинации АКДС3, проведенной на 18, 
22 и 24-й неделе (что соответствует задержке на 1, 2 и 3 месяца 
по сравнению с установленными сроками такой вакцинации, 
проводимой на 6-й и 14-й неделях).
Результаты Для младенцев, имевших сниженную массу 
тела при рож дении (n = 3382) ,  охват  вакцинацией 
АКДС1 был приблизительно на 40% ниже по сравнению 
с  ос тальными м ладенцами (n  = 18 979)  в  возрас те 
10 недель (стандартизированное отношение рисков, СОР: 0,58; 
95%-й ДИ: 0,43–0,77) и в возрасте 18 недель (СОР: 0,63; 95%-й 
ДИ: 0,50–0,80). Охват вакцинацией для младенцев с массой тела 
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1,5–1,9 кг (n = 386) был приблизительно на 25% ниже, чем для 
младенцев с массой тела ≥2,5 кг на тот же момент времени. 
Такие же результаты были получены для АКДС3. Более молодой 
возраст и меньший уровень образования матери, а также 
большее расстояние до ближайшего медицинского учреждения 
коррелировали с меньшим охватом вакцинациями АКДС1 и 
АКДС3.
Вывод Грудные дети со сниженной массой тела при рождении 
входят в группу высокого риска несоблюдения сроков 
вакцинации в Гане. Требуется предпринять меры для повышения 
охвата вакцинацией этих грудных детей, а также провести 
дополнительные исследования для понимания причин задержек.
Resumen
Cronograma de vacunación de los recién nacidos con insuficiencia ponderal en la Ghana rural: un estudio poblacional de 
cohortes prospectivo
Objetivo Investigar los retrasos de la primera y tercera dosis de la vacuna 
contra la difteria, el tétanos y la tos ferina (DTP1 y DTP3) en recién nacidos 
con insuficiencia ponderal en Ghana, así como los determinantes 
relacionados con las mismas.
Métodos En 2010–2013, se utilizaron datos de un ensayo poblacional 
de vitamina A a gran escala basado en la población con 22 955 recién 
nacidos inscritos. Se midió la tasa de vacunación y las características 
tanto de las madres como de los recién nacidos, y se compararon tres 
categorías de recién nacidos con insuficiencia ponderal (2,0–2,4 kg; 
1,5–1,9 kg; y < 1,5 kg) con recién nacidos con un peso de ≥ 2,5 kg. Se 
utilizaron modelos de regresión de Poisson para calcular los coeficientes 
de la tasa de vacunación para DTP1 las semanas 10, 14 y 18 después 
del nacimiento, y para DTP3 las semanas 18, 22 y 24 (lo que equivale 
a 1, 2 y 3 meses tras las fechas de vencimiento de las vacunaciones 
correspondiente de las semanas 6 y 14).
Resultados En comparación con los recién nacidos sin insuficiencia 
ponderal (n = 18 979), los que nacieron con bajo peso (n = 3 382) tenían 
una tasa de inmunización sistemática de DTP1 casi un 40% inferior a 
la edad de 10 semanas (razón de tasa ajustada, aRR: 0,58; IC del 95%: 
0,43–0,77) y a la edad de 18 semanas (aRR: 0,63; IC del 95%: 0,50–0,80). 
Los recién nacidos con un peso de 1,5–1,9 kg (n = 386) tenían unas 
tasas de vacunación de alrededor de un 25% inferior a los que pesaban 
≥ 2,5 kg a la misma edad. Para DTP3 se observaron los mismos resultados. 
Se asociaron la juventud maternal, el bajo nivel educativo y la larga 
distancia hasta la instalación sanitaria más cercana con las bajas tasas 
de vacunación de DTP1 y DTP3.
Conclusión Los recién nacidos con insuficiencia ponderal se encuentran 
en un grupo de alto riesgo para sufrir un retraso de la vacunación en 
Ghana. Se han garantizado esfuerzos para mejorar la vacunación de 
estos recién nacidos, junto con una investigación más profunda para 
comprender las razones de dichos retrasos.
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